These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29031088)

  • 41. Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer's disease.
    Alalwany RH; Hawtrey T; Morgan K; Morris JC; Donaldson LF; Bates DO
    Front Mol Neurosci; 2023; 16():1181626. PubMed ID: 37456522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic silencing of OR and TAS2R genes expression in human orbitofrontal cortex at early stages of sporadic Alzheimer's disease.
    Alves VC; Figueiro-Silva J; Ferrer I; Carro E
    Cell Mol Life Sci; 2023 Jul; 80(8):196. PubMed ID: 37405535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of motion correction on [
    Tiss A; Marin T; Chemli Y; Spangler-Bickell M; Gong K; Lois C; Petibon Y; Landes V; Grogg K; Normandin M; Becker A; Thibault E; Johnson K; El Fakhri G; Ouyang J
    Phys Med Biol; 2023 May; 68(10):. PubMed ID: 37116511
    [No Abstract]   [Full Text] [Related]  

  • 44. Engaging a Non-catalytic Cysteine Residue Drives Potent and Selective Inhibition of Caspase-6.
    Van Horn KS; Wang D; Medina-Cleghorn D; Lee PS; Bryant C; Altobelli C; Jaishankar P; Leung KK; Ng RA; Ambrose AJ; Tang Y; Arkin MR; Renslo AR
    J Am Chem Soc; 2023 May; 145(18):10015-10021. PubMed ID: 37104712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer's disease.
    Khan KM; Balasubramanian N; Gaudencio G; Wang R; Selvakumar GP; Kolling L; Pierson S; Tadinada SM; Abel T; Hefti M; Marcinkiewcz CA
    Acta Neuropathol Commun; 2023 Apr; 11(1):57. PubMed ID: 37009893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acetylcholine and noradrenaline differentially regulate hippocampus-dependent spatial learning and memory.
    de Leo G; Gulino R; Coradazzi M; Leanza G
    Brain Commun; 2023; 5(1):fcac338. PubMed ID: 36632183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities.
    Zhang R; Song Y; Su X
    J Alzheimers Dis; 2023; 94(s1):S367-S386. PubMed ID: 36463451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Manipulation of the diet-microbiota-brain axis in Alzheimer's disease.
    Lee D; Lee VM; Hur SK
    Front Neurosci; 2022; 16():1042865. PubMed ID: 36408394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
    Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target.
    Gutiérrez IL; Dello Russo C; Novellino F; Caso JR; García-Bueno B; Leza JC; Madrigal JLM
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caspase-6-cleaved tau is relevant in Alzheimer's disease and marginal in four-repeat tauopathies: Diagnostic and therapeutic implications.
    Theofilas P; Piergies AMH; Oh I; Lee YB; Li SH; Pereira FL; Petersen C; Ehrenberg AJ; Eser RA; Ambrose AJ; Chin B; Yang T; Khan S; Ng R; Spina S; Seeley WW; Miller BL; Arkin MR; Grinberg LT
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12819. PubMed ID: 35508761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.
    Sirin S; Nigdelioglu Dolanbay S; Aslim B
    J Neural Transm (Vienna); 2022 Jul; 129(7):847-859. PubMed ID: 35429259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease.
    Falgàs N; Allen IE; Spina S; Grant H; Piña Escudero SD; Merrilees J; Gearhart R; Rosen HJ; Kramer JH; Seeley WW; Neylan TC; Miller BL; Rabinovici GD; Grinberg LT; Walsh CM
    Eur J Neurol; 2022 Apr; 29(4):957-967. PubMed ID: 34862834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tubulin and Tubulin Posttranslational Modifications in Alzheimer's Disease and Vascular Dementia.
    Santiago-Mujika E; Luthi-Carter R; Giorgini F; Kalaria RN; Mukaetova-Ladinska EB
    Front Aging Neurosci; 2021; 13():730107. PubMed ID: 34776926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Effective Multimodal Image Fusion Method Using MRI and PET for Alzheimer's Disease Diagnosis.
    Song J; Zheng J; Li P; Lu X; Zhu G; Shen P
    Front Digit Health; 2021; 3():637386. PubMed ID: 34713109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective Effects of Dendrobium nobile Lindl. Alkaloids on Alzheimer's Disease-like Symptoms Induced by High-methionine Diet.
    Pi T; Lang G; Liu B; Shi J
    Curr Neuropharmacol; 2022; 20(5):983-997. PubMed ID: 34370639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
    Dave N; Vural AS; Piras IS; Winslow W; Surendra L; Winstone JK; Beach TG; Huentelman MJ; Velazquez R
    Acta Neuropathol; 2021 Aug; 142(2):279-294. PubMed ID: 33978814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
    Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
    J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.
    Slater C; Wang Q
    Clin Transl Med; 2021 Apr; 11(4):e397. PubMed ID: 33931975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease.
    Karki HP; Jang Y; Jung J; Oh J
    J Nanobiotechnology; 2021 Mar; 19(1):72. PubMed ID: 33750392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.